Becton, Dickinson and Co. (NYSE:BDX)

CAPS Rating: 5 out of 5

Becton Dickinson makes all sorts of medical devices and instruments, including scalpels, syringes, and diagnostic equipment.

Recs

0
Player Avatar THemler (41.24) Submitted: 12/12/2011 1:04:21 PM : Outperform Start Price: $71.59 BDX Score: -3.06

Bought BDX both as short-term defensive & long-term growth prospect. The upside/downside ratio is favorable at current levels. Company is well positoned to grow in emerging markets, but must adjust product costs to truly compete. I'm betting on BDX management to figure it al out and resume their historic consistant growth.

Featured Broker Partners


Advertisement